Paper39455652
In-silico evaluation of the T-cell based immune response against SARS-CoV-2 omicron variants.
Sharma S and 2 others. Sci Rep, 2024. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. In-silico evaluation of the T-cell based immune response against SARS-CoV-2 omicron variants. Papers, record 39455652. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39455652
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- In-silico evaluation of the T-cell based immune response against SARS-CoV-2 omicron variants.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| SARS-CoV-2 | Major topic |
| COVID-19 | Major topic |
| Epitopes, T-Lymphocyte | Major topic |
| Computer Simulation | Major topic |
| Mutation | Major topic |
| Humans | |
| Cross Reactions | |
| CD8-Positive T-Lymphocytes | |
| CD4-Positive T-Lymphocytes | |
| COVID-19 Vaccines | |
| T-Lymphocytes |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 09/0698(13659)/2022-EMR-I | Council of Scientific and Industrial Research, India | PubMed |
Source PubMed
References75
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32680954 | SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection. | Sci Immunol | 2020 | https://conductscience.org/library/papers/32680954 | PubMed |
| 2 | 35105982 | The T cell immune response against SARS-CoV-2. | Nat Immunol | 2022 | https://conductscience.org/library/papers/35105982 | PubMed |
| 3 | 28382917 | GISAID: Global initiative on sharing all influenza data - from vision to reality. | Euro Surveill | 2017 | https://conductscience.org/library/papers/28382917 | PubMed |
| 4 | 33547334 | An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study. | Sci Rep | 2021 | https://conductscience.org/library/papers/33547334 | PubMed |
| 5 | 24058508 | In silico approach for predicting toxicity of peptides and proteins. | PLoS One | 2013 | https://conductscience.org/library/papers/24058508 | PubMed |
| 6 | 10027275 | Protein identification and analysis tools in the ExPASy server. | Methods Mol Biol | 1999 | https://conductscience.org/library/papers/10027275 | PubMed |
| 7 | 24304645 | Designing of interferon-gamma inducing MHC class-II binders. | Biol Direct | 2013 | https://conductscience.org/library/papers/24304645 | PubMed |
| 8 | 34171266 | SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity. | Cell Host Microbe | 2021 | https://conductscience.org/library/papers/34171266 | PubMed |
| 9 | 33225084 | Designing spike protein (S-Protein) based multi-epitope peptide vaccine against SARS COVID-19 by immunoinformatics. | Heliyon | 2020 | https://conductscience.org/library/papers/33225084 | PubMed |
| 10 | 32015507 | A pneumonia outbreak associated with a new coronavirus of probable bat origin. | Nature | 2020 | https://conductscience.org/library/papers/32015507 | PubMed |
| 11 | 34824381 | Heavily mutated Omicron variant puts scientists on alert. | Nature | 2021 | https://conductscience.org/library/papers/34824381 | PubMed |
| 12 | 33112236 | Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. | Elife | 2020 | https://conductscience.org/library/papers/33112236 | PubMed |
| 13 | 32903476 | The Impact of Pre-existing Comorbidities and Therapeutic Interventions on COVID-19. | Front Immunol | 2020 | https://conductscience.org/library/papers/32903476 | PubMed |
| 14 | 34314723 | The origins and potential future of SARS-CoV-2 variants of concern in the evolving COVID-19 pandemic. | Curr Biol | 2021 | https://conductscience.org/library/papers/34314723 | PubMed |
| 15 | 35987196 | SARS-CoV-2 vaccine-induced antibody and T cell response in SARS-CoV-1 survivors. | Cell Rep | 2022 | https://conductscience.org/library/papers/35987196 | PubMed |
| 16 | 35772405 | Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum. | Cell | 2022 | https://conductscience.org/library/papers/35772405 | PubMed |
| 17 | 33664060 | SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8+ T cell responses. | Sci Immunol | 2021 | https://conductscience.org/library/papers/33664060 | PubMed |
| 18 | 35016195 | Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift. | Nature | 2022 | https://conductscience.org/library/papers/35016195 | PubMed |
| 19 | 34634791 | Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity. | Nature | 2021 | https://conductscience.org/library/papers/34634791 | PubMed |
| 20 | 32308001 | Improved Prediction of MHC II Antigen Presentation through Integration and Motif Deconvolution of Mass Spectrometry MHC Eluted Ligand Data. | J Proteome Res | 2020 | https://conductscience.org/library/papers/32308001 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42477893 | Antigenic Variation and Immune Recognition Inference From the COVID-19 Pandemic: An In Silico Comparative Analysis of Spike T Cell Epitopes From the SARS-CoV-2 Variants of Concern. | Influenza Other Respir Viruses | 2026 | https://conductscience.org/library/papers/42477893 | PubMed |
| 41368482 | T-Cell Interferon Gamma Responses to SARS-CoV-2 Following Infection with/Without Vaccination in a Tanzanian Population. | Infect Drug Resist | 2025 | https://conductscience.org/library/papers/41368482 | PubMed |
| 40489562 | Using virtual patient cohorts to uncover immune response differences in cancer and immunosuppressed COVID-19 patients. | PLoS Comput Biol | 2025 | https://conductscience.org/library/papers/40489562 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| HLA-A | 3105 | PubTator's text mining | https://conductscience.org/library/genes/3105 | NCBI Gene |
| HLA-S | 267015 | PubTator's text mining | https://conductscience.org/library/genes/267015 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39455652
GET https://conductscience.org/api/papers/v1/39455652/references?page=2